skip to main content
Show Results with:

Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab

Diem, Stefan et al.

Lung cancer. Volume 111: (2017, September); pp 176-181 -- Elsevier Science Pub. Co

Online access

Searching Remote Databases, Please Wait